TRINITY BIOTECH Directors Purchase Shares in the Company.DUBLIN, Ireland--(BUSINESS WIRE)--March 19, 1998--TRINITY BIOTECH PLC (Nasdaq: TRIBY) announced that members of its Board of Directors had purchased 2,251,000 ordinary shares in the company through the exercise of share options. Mr. Ronan O'Caoimh, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Mr. Brendan Farrell, President, Mr. Jonathan O'Connell, Chief Financial Officer, Mr. Jim Walsh, Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. and Mr. Denis Burger, Director purchased 770,000, 385,000, 400,000, 500,000 and 196,000 ordinary shares respectively. Commenting on the purchase, Mr. Ronan O'Caoimh stated that "this transaction reflects the confidence and belief that the Board of Directors has in the future of Trinity Biotech." TRINITY BIOTECH develops, manufactures and markets over 90 diagnostic products which address all three segments of the diagnostic market: point of care (POC (Proof Of Concept) See PoC exploit. POC - Point Of Contact ), self testing (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). ) and the clinical laboratory. The company's products are sold in over 65 countries worldwide. "Safe Harbor" Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties, including but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration United States Food and Drug Administration (FDA), n.pr a unit of the Public Health Service created to protect the health of the nation against impure and unsafe foods, drugs, and cosmetics. and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the Company's Securities and Exchange Commission filings. CONTACT: TRINITY BIOTECH PLC Jonathan O'Connell, 800/603-8076 or Lippert/Heilshorn Associates, Inc. INVESTOR RELATIONS CONTACT: Olga M. Fleming olga@lhai.com Ruth Markowitz ruth@lhai.com 212/838-3777 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion